“…Several other systems that allow the rapid identification of different bacteria directly from clinical specimens are commercially available. These systems can be based on PCR methods (Biofire ® Filmarray ® , GeneDisc ® , BAX ® System, Cepheid Xpert ® , EntericBio real-time Gastro Panel I ® , FilmArray ® GI panel, Seeplex ® Diarrhea ACE Detection system and xTag ® Gastrointestinal Pathogen Panel, which is a FDA-approved and Health Canada-approved panel for the detection of multiple agents of gastroenteritis), nanoparticles-based technology (Verigene ® platforms, SeptiFast ® , SeptiTest ® ) or peptide nucleic acid fluorescent in situ hybridization (OpGen ® QuickFISH, Accelerate Pheno system) [ 20 , 21 , 22 , 23 , 24 , 117 , 141 ]. Recently, an automated T2Dx instrument platform (T2 Biosystems, Lexington, MD, USA) based on nuclear magnetic resonance technology has been developed that allows the multiplex detection of bacteria from the ESKAPE group in a single whole blood sample without a positive blood culture, in less than 6 h. The detection of bacterial pathogens in other infections, such as respiratory infections, gastroenteritis or sexually transmitted infections isbased on new NAAT technology coupled with different PCR types [ 156 , 157 ].…”